OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
December 16, 2020
A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.
December 11, 2020
Committee recommends Emergency Use Authorization of first mRNA-based COVID-19 vaccine; FDA approval is pending.
December 10, 2020
Evonik offers lipid nanoparticles for gene-based drug development and manufacturing.
December 08, 2020
A development agreement will study inhaled formulations of cannabinoid-based drug product for central nervous system diseases.
December 03, 2020
Janssen announces rolling submissions for its COVID-19 vaccine with Health Canada and EMA.
Operator, caregiver, and patient safety are at the forefront when selecting the best options and dosage forms.
December 02, 2020
The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe.
Transparency and open-dialogue are vital to sway the vaccine-hesitant community.
December 01, 2020
A holistic approach to validation and quality assurance is essential.
November 24, 2020
HMA and EMA have released a joint statement on the appropriate route for companies to submit marketing authorization applications and the approval processes for vaccines.